However, the emergence of immunotherapy, targeting PD-1/ PD-L1 and CTLA-4 pathway blockades to reverse immunosuppressive, appears to become a successful anticancer strategy and is able to induce long-term tumor remission in patients with advanced malignant tumors [43]. The gene discussed is CTLA4; the disease is neoplasm.